http://35.163.211.67/news-release-headline-aenean-vulputate-eleifend-tellus-urabitur-at-lacus-ac-velit-ornare-lobortis-usce-fermentum/ 2025-09-16T00:36:52+00:00 http://35.163.211.67/wp-content/uploads/2025/05/celebrate-logo-1-1.png http://35.163.211.67/phase-3-study-of-novel-anti-platelet-drug-for-heart-attack-reports-positive-topline-results/ 2025-09-23T00:22:13+00:00 http://35.163.211.67/wp-content/uploads/2025/05/celebrate-logo-1-1.png http://35.163.211.67/rapid-zalunfiban-treatment-at-1st-point-of-medical-contact-lowered-risk-of-more-severe-heart-damage-in-combination-with-other-serious-heart-attack-complications/ 2025-11-10T14:02:26+00:00 http://35.163.211.67/wp-content/uploads/2025/05/celebrate-logo-1-1.png http://35.163.211.67/celecor-completes-submission-of-fda-new-drug-application-for-investigational-heart-attack-drug/ 2026-06-24T11:00:00+00:00 http://35.163.211.67/wp-content/uploads/2025/05/celebrate-logo-1-1.png